You are viewing the site in preview mode
Skip to main content
| |
Total
|
Alive or unrelated death
|
Tumour-related death
|
P value
|
|---|
|
Sex
|
|
Female
|
74 (44.0%)
|
11 (42.3%)
|
63 (44.4%)
|
0.846
|
|
Male
|
94 (56.0%)
|
15 (57.7%)
|
79 (55.6%)
| |
|
Race
|
|
White
|
113 (67.3%)
|
17 (65.4%)
|
96 (67.6%)
|
0.960
|
|
Black
|
32 (19.0%)
|
5 (19.2%)
|
27 (19.0%)
| |
|
Other
|
23 (13.7%)
|
4 (15.4%)
|
19 (13.4%)
| |
|
Age at diagnosis
|
|
< 45
|
87 (51.8%)
|
18 (69.2%)
|
69 (48.6%)
|
0.053
|
|
≥ 45
|
81 (48.2%)
|
8 (30.8%)
|
73 (51.4%)
| |
|
Marital status
|
|
Married
|
93 (55.4%)
|
14 (53.8%)
|
79 (55.6%)
|
0.426
|
|
Single
|
41 (24.4%)
|
8 (30.8%)
|
33 (23.2%)
| |
|
Other
|
27 (16.1%)
|
2 (7.7%)
|
25 (17.6%)
| |
|
Unknown
|
7 (4.2%)
|
2 (7.7%)
|
5 (3.5%)
| |
|
Histological grade
|
|
I
|
1 (0.6%)
|
0 (0.0%)
|
1 (0.7%)
|
0.578
|
|
II
|
5 (3.0%)
|
2 (7.7%
|
3 (2.1%
| |
|
III
|
26 (15.5%)
|
3 (11.5%)
|
23 (16.2%)
| |
|
IV
|
29 (17.3%
|
5 (19.2%
|
24 (16.9%
| |
|
Unknown
|
107 (63.7%)
|
16 (61.5%)
|
91 (64.1%)
| |
|
AJCC TNM stage
|
|
I
|
1 (0.6%)
|
11 (42.3%)
|
2 (1.4%)
|
0.064
|
|
II
|
9 (5.4%)
|
0 (0.0%)
|
8 (5.6%)
| |
|
III
|
10 (6.0%)
|
4 (15.4%)
|
6 (4.2%)
| |
|
IV
|
52 (31.0%)
|
0 (0.0%)
|
41 (28.9%)
| |
|
Unstaged
|
96 (57.1%)
|
11 (42.3%)
|
85 (59.9%)
| |
|
Tumour size
|
|
< 3 cm
|
9 (5.4%)
|
3 (11.5%)
|
6 (4.2%)
|
0.104
|
|
3–5 cm
|
32 (19.0%)
|
6 (23.1%)
|
26 (18.3%)
| |
|
> 5 cm
|
63 (37.5%)
|
11 (42.3%)
|
52 (36.6%)
| |
|
Unknown
|
64 (38.1%)
|
6 (23.1%)
|
58 (40.8%)
| |
|
LN metastases
|
|
Yes
|
14 (8.3%)
|
3 (11.5%)
|
11 (7.7%)
|
0.135
|
|
No
|
72 (42.9%)
|
15 (57.7%)
|
57 (40.1%)
| |
|
Unknown
|
82 (48.8%)
|
8 (30.8%)
|
74 (52.1%)
| |
|
Distant metastases
|
|
Yes
|
49 (29.2%)
|
11 (42.3%)
|
38 (26.8%)
|
0.088
|
|
No
|
41 (24.4%)
|
8 (30.8%)
|
33 (23.2%)
| |
|
Unknown
|
78 (46.4%)
|
7 (26.9%)
|
71 (50.0%)
| |
|
Radiation
|
|
Yes
|
44 (26.2%)
|
11 (42.3%)
|
33 (23.2%)
|
0.004
|
|
No/unknown
|
124 (73.8%)
|
15 (57.7%)
|
109 (76.8%)
| |
|
Surgery
|
|
Yes
|
80 (47.6%)
|
14 (53.8%)
|
66 (46.5%)
|
0.489
|
|
No/unknown
|
88 (52.4%)
|
12 (46.2%)
|
76 (53.5%)
| |
|
Summary stage
|
|
Localized
|
33 (19.6%)
|
6 (23.1%)
|
27 (19.0%)
|
0.248
|
|
Regional
|
44 (26.2%)
|
6 (23.1%)
|
38 (26.8%)
| |
|
Distant
|
87 (51.8%)
|
12 (46.2%)
|
75 (52.8%)
| |
|
Unstaged
|
4 (2.4%)
|
2 (7.7%)
|
2 (1.4%)
| |
|
Year of diagnosis
|
|
1973–1988
|
21 (12.5%)
|
1 (3.8%)
|
20 (14.1%)
|
0.045
|
|
1989–2002
|
48 (28.6%)
|
4 (15.4%)
|
44 (31.0%)
| |
|
2003–2013
|
99 (58.9%)
|
21 (80.8%)
|
78 (54.9%)
| |
|
Sequence number
|
|
1st
|
158 (94.0%)
|
25 (96.2%)
|
133 (93.7%)
|
0.622
|
|
2nd
|
10 (6.0%)
|
1 (3.8%)
|
9 (6.3%)
| |